MedTrace Logo

Intensive Glycemic Control and Skeletal Health Study

NCT00324350 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 7287

Last updated 2012-10-05

Study results available
· View outcomes & findings →

Summary

The purpose of the ACCORD-BONE Study is to investigate the effects of intensive glycemic control for type 2 diabetes (in ACCORD participants) on factors related to bone health, including, fractures, falls, and bone mineral density.

Conditions

Interventions

DRUG

hypoglycemic agents, hydroxymethylglutaryl-CoA Reductase inhibitors, hypertensive agents

type 2 diabetes treatments, per standard of care

Sponsors & Collaborators

Principal Investigators

  • Ann V. Schwartz, PhD · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
40 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00324350 on ClinicalTrials.gov